Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Adc therapeutics sa symbols : Abbv save search
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published: 2023-11-01 (Crawled : 18:00) - prnewswire.com
ALPMY | News | $9.46 500K
|
Manufacturing
|
| O: -1.46%
H: 3.67%
C: 3.26%
ZYME | $8.77 -0.9% 130K
|
Health Technology
|
| O: 1.14%
H: 0.42%
C: -0.7%
TAK | $13.185 0.27% 570K
|
Health Technology
|
| O: 1.03%
H: 0.73%
C: 0.58%
ADCT | $4.74 -4.44% 150K
|
Health Technology
|
| O: -0.16%
H: 6.42%
C: 4.49%
ABBV | $165.54 0.78% 2.2M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
STRO M | $3.705 -2.5% 200K
|
Health Technology
|
| O: 0.39%
H: 3.86%
C: 3.86%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 5.09%
H: 5.48%
C: -1.27%
GILD | $66.2 -1.09% 3.3M
|
Health Technology
|
| O: -0.47%
H: 1.88%
C: 1.78%
EXEL | $22.67 -0.88% 1.1M
|
Health Technology
|
| O: -2.62%
H: 1.17%
C: -1.66%
drug antibody breast cancer treatment global market
The Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market is forecast to grow by $ 2061.88 mn during 2022-2027, accelerating at a CAGR of 7.96% during the forecast period
Published: 2023-03-15 (Crawled : 15:20) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.62%
H: 0.0%
C: -3.57%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: -1.0%
H: 1.39%
C: 1.02%
GSK | $39.2 -1.01% 1.2M
|
Health Technology
|
| O: -0.95%
H: 1.05%
C: 0.54%
ADCT | $4.74 -4.44% 150K
|
Health Technology
|
| O: -0.81%
H: 3.48%
C: -0.82%
ABBV | $165.54 0.78% 2.2M
|
Health Technology
|
| O: -1.09%
H: 1.45%
C: 1.24%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: 0.67%
H: 0.67%
C: -2.22%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: -0.08%
H: 2.24%
C: 1.95%
global therapeutics market
Diffuse large B-cell lymphoma (DLBCL) therapeutics market size to increase by USD 2,061.88 million between 2022 and 2027; Growth driven by increasing approval of therapeutics - Technavio
Published: 2023-03-10 (Crawled : 23:00) - prnewswire.com
AMGN | $263.24 -0.31% 760K
|
Health Technology
| Email alert
Add to watchlist
CTIC | $9.09 0.05% 11M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 510
|
Health Technology
| Email alert
Add to watchlist
ABBV | $165.54 0.78% 2.2M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $92.61 -0.51% 430K
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
GSK | $39.2 -1.01% 1.2M
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.74 -4.44% 150K
|
Health Technology
| Email alert
Add to watchlist
approval therapeutics growth market
Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market Size to Grow by USD 1.79 billion, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio
Published: 2022-07-25 (Crawled : 06:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 3.12%
H: 0.06%
C: 0.06%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: 0.19%
GSK | $39.2 -1.01% 1.2M
|
Health Technology
|
| O: 0.76%
H: 0.19%
C: -1.06%
ADCT | $4.74 -4.44% 150K
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: -2.31%
ABBV | $165.54 0.78% 2.2M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: -7.8%
H: 3.72%
C: 2.37%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: 0.37%
H: 0.9%
C: 0.75%
therapeutics market
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-28 (Crawled : 18:31) - fda.gov
ALNY | $144.675 -0.44% 130K
|
Health Technology
| Email alert
Add to watchlist
REGN | $900.22 -0.11% 150K
|
Health Technology
| Email alert
Add to watchlist
INCY | $52.59 -0.25% 880K
|
Health Technology
| Email alert
Add to watchlist
VSTM | $10.67 -1.57% 31K
|
Health Technology
| Email alert
Add to watchlist
EXEL | $22.67 -0.88% 1.1M
|
Health Technology
| Email alert
Add to watchlist
YMAB | $15.23 0.79% 130K
|
Health Technology
| Email alert
Add to watchlist
KPTI | $1.285 -6.88% 890K
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $745.46 -0.71% 940K
|
Health Technology
| Email alert
Add to watchlist
BGNE S | $132.43 0.43% 79K
|
Health Technology
| Email alert
Add to watchlist
ILMN | $117.46 -0.7% 990K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $263.24 -0.31% 760K
|
Health Technology
| Email alert
Add to watchlist
PFE A | $25.325 -0.37% 15M
|
Health Technology
| Email alert
Add to watchlist
BPMC | $90.33 2.21% 410K
|
Health Technology
| Email alert
Add to watchlist
CLVS | $0.0812 -3.94%
|
Health Technology
| Email alert
Add to watchlist
BMY | $47.895 0.12% 4.6M
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.74 -4.44% 150K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
| Email alert
Add to watchlist
RIGL | $1.095 -1.35% 230K
|
Health Technology
| Email alert
Add to watchlist
AGIO | $29.59 1.93% 170K
|
Health Technology
| Email alert
Add to watchlist
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
| Email alert
Add to watchlist
AVEO | $15.0 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
ABBV | $165.54 0.78% 2.2M
|
Health Technology
| Email alert
Add to watchlist
cancer approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-21 (Crawled : 18:33) - fda.gov
PFE A | $25.325 -0.37% 15M
|
Health Technology
|
| O: 0.22%
H: 0.97%
C: -0.65%
LLY | News | $745.46 -0.71% 940K
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: -0.06%
BMY | $47.895 0.12% 4.6M
|
Health Technology
|
| O: 0.36%
H: 1.01%
C: -0.28%
ADCT | $4.74 -4.44% 150K
|
Health Technology
|
| O: 2.54%
H: 0.48%
C: -0.29%
ABBV | $165.54 0.78% 2.2M
|
Health Technology
|
| O: 0.35%
H: 0.65%
C: -1.19%
YMAB | $15.23 0.79% 130K
|
Health Technology
|
| O: 0.58%
H: 1.24%
C: -1.66%
VSTM | $10.67 -1.57% 31K
|
Health Technology
|
| O: 0.63%
H: 2.49%
C: -0.62%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
RIGL | $1.095 -1.35% 230K
|
Health Technology
|
| O: 0.82%
H: 1.08%
C: -1.62%
REGN | $900.22 -0.11% 150K
|
Health Technology
|
| O: 0.18%
H: 0.46%
C: -1.44%
KPTI | $1.285 -6.88% 890K
|
Health Technology
|
| O: 0.31%
H: 1.15%
C: -1.46%
INCY | $52.59 -0.25% 880K
|
Health Technology
|
| O: 0.57%
H: 0.6%
C: -1.46%
ILMN | $117.46 -0.7% 990K
|
Health Technology
|
| O: 0.33%
H: 2.2%
C: 0.21%
EXEL | $22.67 -0.88% 1.1M
|
Health Technology
|
| O: 0.08%
H: 1.64%
C: 0.45%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: -2.62%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.95%
H: 1.31%
C: -2.81%
BPMC | $90.33 2.21% 410K
|
Health Technology
|
| O: 1.12%
H: 0.84%
C: -0.08%
BGNE S | $132.43 0.43% 79K
|
Health Technology
|
| O: 0.1%
H: 1.6%
C: 0.88%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 1.19%
H: 1.71%
C: -0.33%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: 0.71%
H: 0.14%
C: -1.06%
ALNY | $144.675 -0.44% 130K
|
Health Technology
|
| O: 0.38%
H: 1.01%
C: -0.41%
AGIO | $29.59 1.93% 170K
|
Health Technology
|
| O: 0.86%
H: 1.27%
C: -0.24%
cancer approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-20 (Crawled : 18:26) - fda.gov
PFE A | $25.325 -0.37% 15M
|
Health Technology
|
| O: 0.22%
H: 0.97%
C: -0.65%
LLY | News | $745.46 -0.71% 940K
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: -0.06%
BMY | $47.895 0.12% 4.6M
|
Health Technology
|
| O: 0.36%
H: 1.01%
C: -0.28%
ADCT | $4.74 -4.44% 150K
|
Health Technology
|
| O: 2.54%
H: 0.48%
C: -0.29%
ABBV | $165.54 0.78% 2.2M
|
Health Technology
|
| O: 0.35%
H: 0.65%
C: -1.19%
YMAB | $15.23 0.79% 130K
|
Health Technology
|
| O: 0.58%
H: 1.24%
C: -1.66%
VSTM | $10.67 -1.57% 31K
|
Health Technology
|
| O: 0.63%
H: 2.49%
C: -0.62%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
RIGL | $1.095 -1.35% 230K
|
Health Technology
|
| O: 0.82%
H: 1.08%
C: -1.62%
REGN | $900.22 -0.11% 150K
|
Health Technology
|
| O: 0.18%
H: 0.46%
C: -1.44%
KPTI | $1.285 -6.88% 890K
|
Health Technology
|
| O: 0.31%
H: 1.15%
C: -1.46%
INCY | $52.59 -0.25% 880K
|
Health Technology
|
| O: 0.57%
H: 0.6%
C: -1.46%
ILMN | $117.46 -0.7% 990K
|
Health Technology
|
| O: 0.33%
H: 2.2%
C: 0.21%
EXEL | $22.67 -0.88% 1.1M
|
Health Technology
|
| O: 0.08%
H: 1.64%
C: 0.45%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: -2.62%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.95%
H: 1.31%
C: -2.81%
BPMC | $90.33 2.21% 410K
|
Health Technology
|
| O: 1.12%
H: 0.84%
C: -0.08%
BGNE S | $132.43 0.43% 79K
|
Health Technology
|
| O: 0.1%
H: 1.6%
C: 0.88%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 1.19%
H: 1.71%
C: -0.33%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: 0.71%
H: 0.14%
C: -1.06%
ALNY | $144.675 -0.44% 130K
|
Health Technology
|
| O: 0.38%
H: 1.01%
C: -0.41%
AGIO | $29.59 1.93% 170K
|
Health Technology
|
| O: 0.86%
H: 1.27%
C: -0.24%
cancer approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-05 (Crawled : 18:31) - fda.gov
PFE A | $25.325 -0.37% 15M
|
Health Technology
|
| O: -3.73%
H: 1.95%
C: 1.85%
LLY | News | $745.46 -0.71% 940K
|
Health Technology
|
| O: -0.65%
H: 1.33%
C: 1.22%
BMY | $47.895 0.12% 4.6M
|
Health Technology
|
| O: -0.12%
H: 0.19%
C: -0.22%
ADCT | $4.74 -4.44% 150K
|
Health Technology
|
| O: 3.45%
H: 1.01%
C: -0.66%
ABBV | $165.54 0.78% 2.2M
|
Health Technology
|
| O: -0.67%
H: 1.03%
C: 0.94%
YMAB | $15.23 0.79% 130K
|
Health Technology
|
| O: -0.85%
H: 2.64%
C: 2.1%
VSTM | $10.67 -1.57% 31K
|
Health Technology
|
| O: -2.03%
H: 0.82%
C: -1.72%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 0.55%
H: 0.51%
C: 0.29%
RIGL | $1.095 -1.35% 230K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -6.05%
REGN | $900.22 -0.11% 150K
|
Health Technology
|
| O: 0.14%
H: 4.11%
C: 3.22%
KPTI | $1.285 -6.88% 890K
|
Health Technology
|
| O: 0.37%
H: 1.11%
C: 0.0%
INCY | $52.59 -0.25% 880K
|
Health Technology
|
| O: -0.09%
H: 1.99%
C: 1.35%
ILMN | $117.46 -0.7% 990K
|
Health Technology
|
| O: -0.64%
H: 0.34%
C: 0.31%
EXEL | $22.67 -0.88% 1.1M
|
Health Technology
|
| O: -0.88%
H: 0.34%
C: -2.27%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: -9.2%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: -0.34%
H: 0.86%
C: -2.91%
BPMC | $90.33 2.21% 410K
|
Health Technology
|
| O: -0.26%
H: 2.88%
C: 2.72%
BGNE S | $132.43 0.43% 79K
|
Health Technology
|
| O: 0.14%
H: 3.67%
C: 2.67%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -0.3%
H: 0.15%
C: -1.78%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: -0.03%
H: 0.88%
C: 0.81%
ALNY | $144.675 -0.44% 130K
|
Health Technology
|
| O: -0.51%
H: 1.52%
C: 0.08%
AGIO | $29.59 1.93% 170K
|
Health Technology
|
| O: -0.45%
H: 4.45%
C: 3.9%
cancer approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-04-23 (Crawled : 18:42) - fda.gov
LLY | News | $745.46 -0.71% 940K
|
Health Technology
| Email alert
Add to watchlist
RIGL | $1.095 -1.35% 230K
|
Health Technology
| Email alert
Add to watchlist
ILMN | $117.46 -0.7% 990K
|
Health Technology
| Email alert
Add to watchlist
BMY | $47.895 0.12% 4.6M
|
Health Technology
| Email alert
Add to watchlist
BGNE S | $132.43 0.43% 79K
|
Health Technology
| Email alert
Add to watchlist
CLVS | $0.0812 -3.94%
|
Health Technology
| Email alert
Add to watchlist
KPTI | $1.285 -6.88% 890K
|
Health Technology
| Email alert
Add to watchlist
ALNY | $144.675 -0.44% 130K
|
Health Technology
| Email alert
Add to watchlist
PFE A | $25.325 -0.37% 15M
|
Health Technology
| Email alert
Add to watchlist
ABBV | $165.54 0.78% 2.2M
|
Health Technology
| Email alert
Add to watchlist
AGIO | $29.59 1.93% 170K
|
Health Technology
| Email alert
Add to watchlist
VSTM | $10.67 -1.57% 31K
|
Health Technology
| Email alert
Add to watchlist
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
| Email alert
Add to watchlist
REGN | $900.22 -0.11% 150K
|
Health Technology
| Email alert
Add to watchlist
AVEO | $15.0 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
YMAB | $15.23 0.79% 130K
|
Health Technology
| Email alert
Add to watchlist
BPMC | $90.33 2.21% 410K
|
Health Technology
| Email alert
Add to watchlist
EXEL | $22.67 -0.88% 1.1M
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.74 -4.44% 150K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
| Email alert
Add to watchlist
AMGN | $263.24 -0.31% 760K
|
Health Technology
| Email alert
Add to watchlist
INCY | $52.59 -0.25% 880K
|
Health Technology
| Email alert
Add to watchlist
cancer approval
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
ISPC | $0.4621 116.95% 15M
|
Professional, Scientific, and T...
INVO | $1.515 99.34% 4.3M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
SWVL | $9.64 27.35% 200K
|
n/a
DFLI A | $0.7726 25.52% 4.3M
|
Your saved searches
Save your searches and get alerts when important news are released.